The effect of blackcurrants on platelet monoamine-oxidase enzyme activity.

Not Applicable

• Conditions: eurotransmitter modulation; Neurotransmitter modulation; Neurological - Studies of the normal brain and nervous system

• Registration Number: ACTRN12624000021572
• Lead Sponsor: Dr Jocelyn Eason

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2024-01-11
• Last Update Posted: 15 January 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 4

Inclusion Criteria

Healthy individual (male or female) 18 – 50 years who are able to provide written consent to participate when selected for this study, are non-smokers and vapers and are not prescribed psychotropic medication or MAO inhibitors.

Exclusion Criteria

Participants will be excluded if they are unwilling to unable to provide written consent or comply with the study procedures. Participants will be excluded if they are pregnant, planning to get pregnant in the immediate future or have any of the following conditions: (i) blood borne diseases (e.g. hepatitis), (ii) recent bacterial or viral illness, (iii) are taking medication that affects the properties of blood (e.g. blood clotting) or immune function, (iv) are taking medication for mental health and mood disorders, (v) have a strong fear or dislike of needles and/or the sight of blood, have an aversion to blood sampling, or difficult veins to access.

Participants will be excluded if they have known hypersensitivity or intolerance to blackcurrants or blackcurrant derived foods.

Study & Design

• Study Type: Interventional
• Study Design: Not specified